This news is delayed by 15 minutes, sign up now to get live news & full features.
ACLX ARCELLX INC
+ add to watchlist
$114.72
Arcellx Inc. is a clinical-stage biotechnology company. The Company is focused developing controllable cell therapies for the treatment of patients with cancer and other incurable diseases.
Mkt Cap: $6.71B
52 Week High: $114.91
P/E: 0.00
52 Week Low: $47.86
Dividend: $0.00
Shares Outstanding: 58.48M